Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
About this episode
Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and practical considerations with ovarian function suppression for hormone receptor-positive breast cancer.
Get every episode summarized
Each time Breast Cancer Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breast Cancer Update
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and...
Breast Cancer Update
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Breast Cancer Update
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant N...
Breast Cancer Update
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San A...
Breast Cancer Update